Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
19.29
-1.03 (-5.07%)
At close: Mar 31, 2025, 4:00 PM
19.54
+0.25 (1.30%)
After-hours: Mar 31, 2025, 7:38 PM EDT
Summit Therapeutics Employees
Summit Therapeutics had 159 employees as of December 31, 2024. The number of employees increased by 54 or 51.43% compared to the previous year.
Employees
159
Change (1Y)
54
Growth (1Y)
51.43%
Revenue / Employee
n/a
Profits / Employee
-$1,391,918
Market Cap
14.23B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 159 | 54 | 51.43% |
Dec 31, 2023 | 105 | 28 | 36.36% |
Dec 31, 2022 | 77 | -33 | -30.00% |
Dec 31, 2021 | 110 | 29 | 35.80% |
Dec 31, 2020 | 81 | 11 | 15.71% |
Dec 31, 2019 | 70 | 9 | 14.75% |
Dec 31, 2018 | 61 | -15 | -19.74% |
Dec 31, 2017 | 76 | 36 | 90.00% |
Dec 31, 2016 | 40 | 3 | 8.11% |
Dec 31, 2015 | 37 | 14 | 60.87% |
Dec 31, 2014 | 23 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SMMT News
- 7 days ago - Analyst Initiates Coverage On 'Undervalued' Summit Therapeutics - Benzinga
- 10 days ago - Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 14 days ago - Robert LaCaze, Innovative Growth-Driver in Oncology, Joins Summit Therapeutics as Chief Commercial Officer - Business Wire
- 5 weeks ago - Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs - PRNewsWire
- 5 weeks ago - Summit Therapeutics: Mid-2025 NSCLC Data Could Further Entrench Ivonescimab Program - Seeking Alpha
- 5 weeks ago - Summit Therapeutics Inc. (SMMT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Pfizer: What The Summit Therapeutics Deal Brings - Seeking Alpha
- 5 weeks ago - Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Twelve Months Ended December 31, 2024 - Business Wire